Parent-Adolescent Interactions and Adolescent Development (PAIT)

August 6, 2019 updated by: Tara M. Chaplin, Ph.D., George Mason University

Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.

The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.

Study Overview

Status

Completed

Conditions

Detailed Description

The study examines parenting behaviors and adolescent emotional responses during parent-adolescent interactions and whether these predict youth's current and future substance use over a 3 year follow-up.

Study Type

Observational

Enrollment (Actual)

245

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale Stress Center
    • Virginia
      • Fairfax, Virginia, United States, 22030
        • George Mason University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 14 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

12-14 year olds and their primary caregivers.

Description

Inclusion Criteria:

  • Adolescent between ages 12-14 years

Exclusion Criteria:

  • For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write.
  • Evidence of a psychotic disorder for parent or adolescent
  • Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening.
  • For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening.
  • For adolescent and parent, inadequate English proficiency to comprehend task instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
12-14 year olds
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Substance Use
Time Frame: Baseline
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
Baseline
Substance Use
Time Frame: 6 month follow-up
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
6 month follow-up
Substance Use
Time Frame: 1 year follow-up
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
1 year follow-up
Substance Use
Time Frame: 2 year follow-up
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
2 year follow-up
Substance Use
Time Frame: 3 year follow-up
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
3 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tara Chaplin, Ph.D., Yale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2013

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

April 3, 2012

First Submitted That Met QC Criteria

April 5, 2012

First Posted (Estimate)

April 6, 2012

Study Record Updates

Last Update Posted (Actual)

August 7, 2019

Last Update Submitted That Met QC Criteria

August 6, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 0909005677
  • R01DA033431 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We will make data from the proposed laboratory study available to other researchers, after de-identifying study data and after publishing the main manuscripts on the study.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Subscribe